CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity
Kozlov I., Beason K., Yu C., and Hughson M. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity. Cancer Genet Cytogenet 163 (2005) 62-67
Acute myeloid leukemia with t(8;21)(q22;q22)/AML1/ETO: a distinct biological and clinical entity
Ferrara F., and Del Vecchio L. Acute myeloid leukemia with t(8;21)(q22;q22)/AML1/ETO: a distinct biological and clinical entity. Haematologica 87 (2002) 306-319
Molecular detection of t(8,21)/AML1/ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype
Andrieu V., Radford-Weiss I., Troussard X., Chane C., Valensi F., Guesnu M., Haddad E., Viguier F., Dreyfus F., Varet B., Flandrin G., and Macintyre E. Molecular detection of t(8,21)/AML1/ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Haematol 92 (1996) 855-865
AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemia
Kuchenbauer F., Feuring-Buske M., and Buske C. AML1-ETO needs a partner: new insights into the pathogenesis of t(8;21) leukemia. Cell Cycle 4 (2005) 1716-1718
AML1/ETO-expressing non-leukemia stem cells in acute myelogenous leukemia with t(8;21) chromosomal translocation
Miyamoto T., Weissman I.L., and Akashi K. AML1/ETO-expressing non-leukemia stem cells in acute myelogenous leukemia with t(8;21) chromosomal translocation. Proc Natl Acad Sci U S A 97 (2000) 7521-7526
AML1 (CBFα2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter
Libermann T.A., Pan Z., Akbarali Y., Hetherington C.J., Boltax J., Yergeau D.A., and Zhang D.E. AML1 (CBFα2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter. J Biol Chem 274 (1999) 24671-24676
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt S.L., Heavey B., Rolink A.G., and Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401 (1999) 556-562
The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP
Kozmik Z., Wang S., Dorfler P., Adams B., and Busslinger M. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol Cell Biol 12 (1992) 2662-2672
Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments
Nutt S.L., Morrison A.M., Dorfler P., Rolink A., and Busslinger M. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J 17 (1998) 2319-2333
Lineage-specific regulation of the murine RAG-2 promoter: GATA-3 in T cells and Pax-5 in B cells
Kishi H., Wei X.C., Jin Z.X., Fujishiro Y., Nagata T., Matsuda T., and Muraguchi A. Lineage-specific regulation of the murine RAG-2 promoter: GATA-3 in T cells and Pax-5 in B cells. Blood 95 (2000) 3845-3852